Public Joint-Stock Company "Human Stem Cells Institute"

MISX:ISKJ Rapporto sulle azioni

Cap. di mercato: ₽4.3b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Human Stem Cells Institute Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Prikhodko Viktorovich

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO1.4%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Public Joint-Stock Company "Human Stem Cells Institute" (MCX:ISKJ)

May 09
Risks To Shareholder Returns Are Elevated At These Prices For Public Joint-Stock Company "Human Stem Cells Institute" (MCX:ISKJ)

Is Human Stem Cells Institute (MCX:ISKJ) Using Too Much Debt?

Dec 25
Is Human Stem Cells Institute (MCX:ISKJ) Using Too Much Debt?

We Wouldn't Rely On Human Stem Cells Institute's (MCX:ISKJ) Statutory Earnings As A Guide

Nov 19
We Wouldn't Rely On Human Stem Cells Institute's (MCX:ISKJ) Statutory Earnings As A Guide

AMMINISTRATORE DELEGATO

Prikhodko Viktorovich (63 yo)

no data

Mandato

Mr. Prikhodko Alexander Viktorovich, Ph D., served as Chairman of the Board of Public Joint-Stock Company "Human Stem Cells Institute" since July 30, 2012 until October 2020 and serves as its General Direc...